Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 25.3.20251 Min. Lesezeit
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →